We are honoured to share that Mathys & Squire is a Gold sponsor of Life Sciences Patent Network (LSPN) 2025, taking place on May 6-7 in Boston. Partners Hazel Ford, Alexander Robinson, Philippa Griffin and Managing Associate Sarah Turp will be attending the event in person.
The Life Sciences IP Review is the principal online publication for professionals in the IP industry across the areas of pharmaceuticals, biotechnology and medical technology.
Every year, The Life Sciences IP Review organise LSPN to connect top patent experts and pioneers in innovative technology from around the globe. The event provides a pivotal opportunity to engage with industry leaders and discover cutting-edge advice in protecting and leveraging innovation in the fields of life sciences.
The program offers expert-led sessions and interactive panels, designed to share a wide range of expertise in the latest legal rulings, legislative changings and strategic approaches in the life sciences IP landscape. On 6 May, Partners Hazel Ford and Alex Robinson will be speaking about the changing landscape within the EPO and recent decisions on granted European patents from the newly formed UPC. They will be sharing their in-depth knowledge on how the approach of the EPO Boards of Appeal is shifting and the implications for a pan-European patent strategy.
You can learn more about the event here.
